KLRK1 and Miyoshi myopathy: In MM, but not MGUS, myeloma cells shed soluble MHC class I-related chain A (sMICA), resulting in downregulation of NKG2D expression, impaired lymphocytotoxicity, and resistance to NKG2D-mediated killing (81–83).